A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2

Lindsey A Loomba-Albrecht, Maryam Jame, Andrew A. Bremer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Maturity-onset diabetes of the young (MODY) is a group of disorders accounting for 2-5% of diabetes; MODY2 is caused by inactivating GCK mutations. We report a case of MODY2 caused by a novel GCK mutation and demonstrate differential glycemic/C-peptide responses to treatment with insulin, no medication, and an oral sulfonylurea.

Original languageEnglish (US)
JournalDiabetes Research and Clinical Practice
Volume87
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Glucokinase
C-Peptide
Mutation
Genes
Insulin
Maturity-Onset Diabetes of the Young, Type 2
Therapeutics
Mason-Type Diabetes

Keywords

  • Glucokinase
  • MODY2
  • Sulfonylurea

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology

Cite this

@article{2af1df3f0ea34092b0d7f28f2217787e,
title = "A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2",
abstract = "Maturity-onset diabetes of the young (MODY) is a group of disorders accounting for 2-5{\%} of diabetes; MODY2 is caused by inactivating GCK mutations. We report a case of MODY2 caused by a novel GCK mutation and demonstrate differential glycemic/C-peptide responses to treatment with insulin, no medication, and an oral sulfonylurea.",
keywords = "Glucokinase, MODY2, Sulfonylurea",
author = "Loomba-Albrecht, {Lindsey A} and Maryam Jame and Bremer, {Andrew A.}",
year = "2010",
month = "3",
doi = "10.1016/j.diabres.2009.11.013",
language = "English (US)",
volume = "87",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2

AU - Loomba-Albrecht, Lindsey A

AU - Jame, Maryam

AU - Bremer, Andrew A.

PY - 2010/3

Y1 - 2010/3

N2 - Maturity-onset diabetes of the young (MODY) is a group of disorders accounting for 2-5% of diabetes; MODY2 is caused by inactivating GCK mutations. We report a case of MODY2 caused by a novel GCK mutation and demonstrate differential glycemic/C-peptide responses to treatment with insulin, no medication, and an oral sulfonylurea.

AB - Maturity-onset diabetes of the young (MODY) is a group of disorders accounting for 2-5% of diabetes; MODY2 is caused by inactivating GCK mutations. We report a case of MODY2 caused by a novel GCK mutation and demonstrate differential glycemic/C-peptide responses to treatment with insulin, no medication, and an oral sulfonylurea.

KW - Glucokinase

KW - MODY2

KW - Sulfonylurea

UR - http://www.scopus.com/inward/record.url?scp=77649178668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649178668&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2009.11.013

DO - 10.1016/j.diabres.2009.11.013

M3 - Article

C2 - 20015564

AN - SCOPUS:77649178668

VL - 87

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 3

ER -